Pacific Biosciences is trading 10.44% up at $2.48 on October 27, 2026, with no clear company-specific announcement identified to explain the move.
- The company’s press-release listing shows its latest collaboration announcement was on October 19.
- Biotech stocks are benefiting from positive clinical-trial and regulatory news, while major indexes are also higher. This backdrop may be contributing, but available reporting does not establish a direct cause for Pacific Biosciences’ move.